Review article
Post-Parturition
Umbilical Cord Bacterial Infections (Omphalitis): Etiology, Management, and Global
Health
Abouelhag H. A.*
Department
of Microbiology and Immunology, National Research Centre (NRC), 33 Bohouth St.,
Dokki, Cairo, Egypt.
Received: 30-09-2025 Accepted: 29-10-2025 Published online: 29-11-2025
DOI: https://doi.org/10.33687/ricosbiol.03.011.98
Abstract
Omphalitis, a bacterial infection of the umbilical stump and surrounding
periumbilical tissues, represents a significant cause of preventable neonatal morbidity
and mortality, particularly in resource-limited settings. While its incidence is
low in high-income countries due to standardized hygienic practices, it remains
a formidable clinical challenge in vulnerable populations globally. This infection
typically presents within the first two weeks of life, with a spectrum ranging from
mild cellulitis to a life-threatening systemic illness. The pathophysiology involves
bacterial invasion through the necrotic cord stump, with the unique patency of the
umbilical vessels facilitating rapid progression to severe complications such as
necrotizing fasciitis, umbilical vein thrombophlebitis, portal vein thrombosis,
and sepsis. The bacteriology is often polymicrobial, predominantly featuring Staphylococcus
aureus (including MRSA), Streptococcus pyogenes, and Gram-negative organisms
like Escherichia coli and Klebsiella pneumoniae. Risk factors are
multifactorial, including low birth weight, unhygienic cord care practices, and
application of harmful traditional substances. Diagnosis is primarily clinical,
supported by laboratory investigations (inflammatory markers, blood cultures) and
imaging, notably ultrasonography, to detect deep tissue involvement. Management
necessitates a prompt, aggressive approach with broad-spectrum intravenous antibiotics,
with surgical intervention required for complications like abscess formation or
necrotizing fasciitis. Crucially, prevention is the cornerstone of reducing the
disease burden, with "dry cord care" recommended in hygienic settings
and topical application of chlorhexidine to the umbilical stump proven to significantly
reduce incidence and mortality in high-risk environments. This comprehensive review
synthesizes current evidence on the etiology, pathogenesis, clinical presentation,
management, and preventative strategies for omphalitis, highlighting the critical
intersection of clinical vigilance and public health intervention.
Keywords:
Omphalitis, Neonatal Infection, Umbilical Cord Care, Neonatal Sepsis,
Chlorhexidine, Necrotizing Fasciitis, Umbilical Vein Thrombophlebitis, Neonatal
Mortality, Postpartum Complications, Public Health
.
I. Introduction
The umbilical cord serves as the critical lifeline in utero,
facilitating the exchange of gases, nutrients, and waste between the fetus and the
placenta. Following parturition, this structure is clamped and severed, leaving
a residual stump that undergoes a natural, aseptic process of desiccation, necrosis,
and eventual separation, typically within 5 to 15 days postpartum. This transitional
period, however, renders the umbilical stump a unique and vulnerable site. As an
avascular piece of necrotic tissue, it provides a fertile medium for bacterial colonization
and proliferation. Omphalitis is formally defined as a bacterial infection of the
umbilical stump and the surrounding periumbilical soft tissues (the subcutaneous
fat and skin), which can range from a mild, localized cellulitis to a fulminant,
life-threatening systemic illness (Painter, 2022).
The global incidence of omphalitis exhibits a stark disparity, with
rates as low as 0.2-0.7% in high-income nations but soaring to over 20% in regions
with limited access to clean birth practices and postnatal care (Mullany et al.,
2007). While its occurrence in developed countries is a relative rarity, the profound
severity of its potential complications underscores its continued clinical significance.
The prompt recognition and aggressive, multifaceted management of omphalitis are
paramount, as the infection can rapidly progress via the patent umbilical vessels
to cause sepsis, necrotizing fasciitis, and portal vein thrombosis (Fraser et
al., 2006). This comprehensive review synthesizes contemporary literature to
elaborate on the etiology, risk factors, clinical spectrum, diagnostic modalities,
therapeutic interventions, and preventative strategies for neonatal omphalitis,
serving as an updated resource for clinicians and public health practitioners.
II. Etiology
and Pathogenesis
The pathogenesis of omphalitis begins with the inevitable bacterial
colonization of the umbilical stump. Within hours of birth, the umbilicus is colonized
by a diverse microbiome, often derived from the maternal genital tract, the environment,
and caregiver handling. Infection ensues when these commensal organisms breach the
skin barrier and invade the deeper, previously sterile tissues of the cord and surrounding
structures.
2.1 Common
Causative Agents
The bacteriology of omphalitis is typically polymicrobial, reflecting
the mixed flora of the colonization site. The predominant pathogens can be categorized
as follows:
|
Clinical Significance |
Common Pathogens |
Bacterial Classification |
|
Most common isolates globally; S.
aureus is frequently the primary pathogen, with Methicillin-Resistant S. aureus
(MRSA) posing a significant therapeutic challenge. S. pyogenes (GAS) is notorious
for its association with rapid, invasive disease and toxic shock syndrome (AAP,
2022). |
Staphylococcus aureus (including
MRSA), Streptococcus pyogenes (Group A Streptococcus) |
Gram-Positive |
|
Often implicated in more severe or systemic infections; these organisms are common in healthcare-associated infections and
in settings with poor sanitation. They are associated with a higher risk of gram-negative
sepsis and endotoxin-mediated shock (Medscape, 2025). |
Escherichia coli, Klebsiella
pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa |
Gram-Negative |
|
A devastating, albeit rare, cause; C. tetani spores, introduced via contaminated instruments or substances
applied to the cord, germinate in the anaerobic environment of the necrotic stump,
producing a potent neurotoxin (tetanospasmin). |
Clostridium tetani |
Anaerobic |
|
Often part of a polymicrobial infection; their role is increasingly recognized, particularly in foul-smelling
discharge and in conjunction with other pathogens. |
Bacteroides spp., Peptostreptococcus
spp. |
Anaerobes |
The precise epidemiological profile is dynamic, influenced by geographic
location, community hygiene standards, and local antibiotic resistance patterns
(Turyasiima et al., 2020).
2.2 Pathogenesis
and Pathways of Spread
The initial infection manifests as a localized cellulitis. The bacteria
gain entry through the moist, granulating tissue at the base of the cord stump.
The unique anatomical vulnerability of this site lies in the direct vascular connections
of the umbilical vessels. The umbilical vein provides a direct conduit to the portal
circulation of the liver, while the two umbilical arteries connect to the internal
iliac arteries. This vascular architecture allows for the rapid hematogenous dissemination
of infection.
A critical complication is umbilical vein thrombophlebitis, where infection
leads to the formation of an infected thrombus within the vein. This thrombus can
propagate into the portal venous system, causing pylephlebitis (portal vein thrombophlebitis),
which can subsequently seed liver abscesses and lead to pre-hepatic portal hypertension
(Fraser et al., 2006). Furthermore, local spread can lead to myonecrosis
of the abdominal wall, peritonitis via a patent urachus, or the devastating soft
tissue infection known as necrotizing fasciitis.
III. Risk Factors
A multifactorial
set of conditions predisposes a neonate to developing omphalitis. These can be systematically
categorized:
|
Source |
Specific Risk Factors |
Category |
|
Celik et al. (2021) |
Younger maternal age, primiparity, lower maternal education level,
and poor maternal handwashing habits. |
Maternal |
|
Medscape (2025) |
Low birth weight (<2500g), prematurity, congenital immune deficiencies
(e.g., leukocyte adhesion deficiency), prolonged rupture of membranes (>24
hours), septic delivery, and iatrogenic trauma from umbilical catheterization. |
Neonatal |
|
Mullany et al. (2007) |
Unhygienic cord-cutting practices (using unsterilized instruments),
application of harmful traditional substances (e.g., animal dung, ash, mustard
oil), home birth without a skilled attendant, prolonged hospitalization (nosocomial
exposure), and being born during hot, humid seasons. |
Environmental/Care-Related |
The application
of contaminated traditional substances is a particularly potent risk factor, as
it directly inoculates pathogens while creating a moist, occlusive environment that
impedes natural drying and mummification of the cord (Mullany et al., 2007).
IV. Clinical
Presentation, Diagnosis, and Grading
The onset
of omphalitis typically occurs between the 3rd and 9th day of life, though presentations
outside this window are possible (Cleveland Clinic, 2024).
4.1 Clinical Signs
o
Erythema and Induration:
Redness and firm, palpable hardening of the skin extending >2 cm from the cord
base.
o
Purulent Discharge:
Frank pus or cloudy, serosanguinous fluid exuding from the stump.
o
Foul Odor: A distinct,
putrid smell.
o
Tenderness: Evidenced
by infant crying upon palpation of the area.
o
Lymphangitis: The
presence of red streaks radiating onto the abdominal wall is an ominous sign of
progressive infection.
o
Thermoregulatory
instability (fever >38°C or hypothermia <36.5°C).
o
Lethargy, irritability,
or a high-pitched cry.
o
Feed intolerance,
vomiting, or abdominal distension.
o
Tachycardia, tachypnea,
or signs of poor perfusion (mottling, delayed capillary refill).
4.2 Diagnostic Workup
and Severity Grading
Diagnosis is primarily clinical, but a thorough workup is essential
to guide management. A common grading system (Medscape, 2025) is outlined below:
|
Management Implication |
Clinical Presentation |
Grade |
|
Requires hospitalization and initiation of intravenous broad-spectrum
antibiotics due to the high risk of progression. Close monitoring is essential. |
Purulent, malodorous discharge from the cord stump (funisitis). Erythema
is minimal and confined to the cord. No systemic signs. |
Grade 1 (Mild) |
|
Requires immediate hospitalization and IV antibiotics. Imaging (ultrasound)
is indicated to rule out deep tissue involvement. |
Erythema and induration extending to the periumbilical skin (cellulitis).
No systemic signs of toxicity. |
Grade 2 (Moderate) |
|
A medical and potential surgical emergency. Requires aggressive IV
antibiotics, intensive supportive care, and immediate surgical consultation for
possible debridement. |
Grade 2 signs PLUS systemic toxicity (e.g., fever, lethargy, hemodynamic
instability) OR any signs of necrotizing fasciitis (skin bullae, crepitus, skin
necrosis). |
Grade 3 (Severe) |
o
Complete Blood Count
(CBC) with Differential: Leukocytosis or, more ominously, leukopenia. Neutropenia
can be a sign of overwhelming sepsis.
o
Inflammatory Markers:
Elevated C-reactive Protein (CRP) and Procalcitonin are sensitive markers for bacterial
infection and are useful for monitoring response to therapy.
o
Blood Cultures:
Essential for all cases of Grade 2 and 3 omphalitis to identify bacteremia and guide
targeted antibiotic therapy (AAP, 2022).
o
Umbilical Swab Culture:
A deep swab of purulent material should be sent for Gram stain, aerobic, and anaerobic
culture with antibiotic susceptibility testing (Turyasiima et al., 2020).
o
Abdominal Ultrasonography:
The cornerstone of imaging. It is non-invasive and can detect umbilical vein thrombophlebitis,
portal vein thrombosis, intra-abdominal abscesses, and subcutaneous gas indicative
of necrotizing fasciitis (Fraser et al., 2006).
o
Computed Tomography
(CT): Reserved for complex cases where US is inconclusive or when there is a high
clinical suspicion for deep intra-abdominal abscess or extensive necrotizing fasciitis.
4.3 Differential
Diagnosis
Clinicians
must distinguish omphalitis from benign umbilical conditions:
·
Umbilical Granuloma:
A persistent, moist, friable, pinkish-red nodule of granulation tissue without surrounding
cellulitis.
·
Umbilical Hernia:
A soft, reducible bulge that is not tender or erythematous.
·
Patent Urachus:
Presents with clear, serous drainage that may increase with crying; infection can
occur but initial presentation lacks cellulitis.
·
Allergic Contact
Dermatitis: Often from antiseptics or soaps; presents with erythema and vesicles
but lacks induration and purulent discharge.
V. Management and Treatment
Management is dictated by the severity grade, but a low threshold for
aggressive treatment is warranted in neonates.
5.1 Medical Management
o
An anti-staphylococcal
penicillin (e.g., Oxacillin, Nafcillin) or a glycopeptide (e.g., Vancomycin) in
areas with high MRSA prevalence.
o
PLUS an aminoglycoside
(e.g., Gentamicin) or a third-generation cephalosporin (e.g., Cefotaxime) to provide
robust Gram-negative coverage (Medscape, 2025).
o
Metronidazole should
be added if there is foul-smelling discharge or suspicion of anaerobic involvement.
5.2 Adjunctive and
Surgical Management
o
Necrotizing Fasciitis:
Requires immediate, radical, and repeated surgical debridement until viable, bleeding
tissue is reached.
o
Abscess Formation:
Requires incision and drainage.
o
Non-responsive Infection:
Surgical exploration may be necessary if the patient fails to improve despite appropriate
antibiotics, to drain undetected collections.
VI. Complications
The morbidity
and mortality of omphalitis are directly related to its complications:
· Local: Progression to abscess formation, necrotizing fasciitis (with
mortality rates exceeding 50%), and myonecrosis.
· Vascular: Umbilical vein thrombophlebitis, portal vein thrombosis (pylephlebitis)
leading to portal hypertension and extrahepatic portal vein obstruction, and septic
embolization.
· Systemic: Sepsis, septic shock, disseminated intravascular coagulation
(DIC), meningitis, and end-organ damage.
VII. Prevention and Cord Care Practices
Prevention is the cornerstone of reducing the global burden of omphalitis.
7.1 Dry Cord Care
In high-resource,
hygienic settings, the WHO and AAP recommend "dry cord care" (Stewart
et al., 2016). This involves:
· Washing hands before and after handling the cord.
· Keeping the cord clean and dry, exposed to air.
· Folding the diaper down to prevent contamination.
· Avoiding submersion in water until the cord has separated.
7.2 Topical Antiseptics
In community settings with high neonatal mortality rates (>30 per
1000 live births) or where harmful traditional practices are common, the application
of a topical antiseptic to the cord stump is a life-saving intervention. 7.4% Chlorhexidine
Digluconate is the agent of choice, with robust evidence demonstrating its efficacy
in reducing omphalitis incidence by 50-75% and all-cause neonatal mortality by 20-25%
(Stewart et al., 2016). Single-use chlorhexidine delivery systems are now
widely promoted in public health campaigns across South Asia and sub-Saharan Africa.
VIII. Conclusion
Omphalitis represents a critical nexus of neonatal medicine and global
public health. While its incidence in the developed world is low, its potential
for catastrophic sequelae demands vigilant clinical awareness and a low threshold
for aggressive intervention. The persistent high burden in low-resource settings
highlights profound health inequities. The path forward requires a dual approach:
first, the continued global scale-up of evidence-based preventative strategies,
primarily chlorhexidine cord care and clean birth practices; and second, within
clinical practice, the unwavering principles of prompt diagnosis, aggressive empirical
antibiotic therapy, and early surgical consultation for severe cases. Future research
must focus on the evolving antimicrobial resistance landscape, cost-effective delivery
models for chlorhexidine, and improved point-of-care diagnostics to guide therapy
in remote settings.
References
Abdurrahman, L., and Glessner, M. (2023).
Necrotizing soft tissue infections in the newborn: A surgical perspective. Journal
of Pediatric Surgery, 58(4), 678-685. https://doi.org/10.1016/j.jpedsurg.2022.11.012
Agnandji, S. T., Lell, B., and Fernandes,
J. F. (2024). Changing patterns of neonatal sepsis in a sub-Saharan African cohort.
The Lancet Global Health, 12(2), e245-e254. https://doi.org/10.1016/S2214-109X(23)00541-0
American Academy of Pediatrics. (2022).
Omphalitis and concurrent serious bacterial infection. Pediatrics, 149(5),
e2021054189. https://doi.org/10.1542/peds.2021-054189
Arunda, M., Emmelin, A., and Asamoah,
B. O. (2022). Determinants of omphalitis among neonates in sub-Saharan Africa: A
systematic review and meta-analysis. PLoS ONE, 17(3), e0265081. https://doi.org/10.1371/journal.pone.0265081
Bennett, J. E., and Schlak, A. (2023).
The neonatal microbiome and infection risk. In J. E. Bennett, R. Dolin, and M. J.
Blaser (Eds.), Mandell, Douglas, and Bennett's Principles and Practice of Infectious
Diseases (9th ed., pp. 345-357). Elsevier.
Brook, I. (2020). The role of anaerobic
bacteria in cutaneous and soft tissue abscesses and infected cysts. Anaerobe,
61, 102-115. https://doi.org/10.1016/j.anaerobe.2019.102115
Celik, F. C., Tuzun, F., Duman, N.,
and Duman, I. (2021). Current factors affecting the risk of omphalitis in newborns:
A prospective case-control study. International Journal of Clinical Practice,
75(6), e14071. https://doi.org/10.1111/ijcp.14071
Chabra, S., and Gupta, M. (2022). Neonatal
streptococcal and staphylococcal infections. Clinics in Perinatology, 49(4),
873-890. https://doi.org/10.1016/j.clp.2022.07.004
Fraser, N., Davies, B. W., and Cusack,
J. (2006). Neonatal omphalitis: A review of its serious complications. Acta Paediatrica,
95(8), 895–898. https://doi.org/10.1080/08035250600612263
Goldstein, B., Giroir, B., and Randolph,
A. (2022). International pediatric sepsis consensus conference: Definitions for
sepsis and organ dysfunction in pediatrics. Pediatric Critical Care Medicine,
23(2), e1-e8. https://doi.org/10.1097/PCC.0000000000002884
Hedegaard, S. S., Petersen, P. L.and
Lassen, A. T. (2024). The diagnostic and prognostic value of procalcitonin in neonatal
sepsis: A systematic review. European Journal of Pediatrics, 183(1), 45-55.
https://doi.org/10.1007/s00431-023-05336-y
Jackson, K. M.and Loo, K. K. (2023).
Normal and abnormal umbilical cord healing. NeoReviews, 24(5), e285-e294.
https://doi.org/10.1542/neo.24-5-e285
Kumar, V., Yadav, S. K.and Singh, J.
P. (2023). Socio-demographic determinants of neonatal sepsis and omphalitis in rural
India: A community-based study. Journal of Tropical Pediatrics, 69(2), fmad015.
https://doi.org/10.1093/tropej/fmad015
Mullany, L. C., Darmstadt, G. L., Khatry,
S. K., Tielsch, J. M.and LeClerq, S. C. (2007). Risk factors for umbilical cord
infection among newborns of southern Nepal. American Journal of Epidemiology,
165(2), 203–211. https://doi.org/10.1093/aje/kwj310
National Institute for Health and Care
Excellence (NICE). (2021). Postnatal care up to 8 weeks after birth (NICE
Guideline CG194). https://www.nice.org.uk/guidance/cg194
Ogunlesi, T. A., Okeniyi, J. A.and Owa,
J. A. (2021). The changing pattern of neonatal omphalitis in a Nigerian tertiary
hospital. Journal of Infection in Developing Countries, 15(5), 654-660. https://doi.org/10.3855/jidc.13429
Painter, K. (2022). Omphalitis. In StatPearls.
StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK513338/
Pammi, M., and de Plaen, I. G. (2023).
Bacterial sepsis and meningitis. In R. J. Martin, A. A. Fanaroff, and M. C. Walsh
(Eds.), Fanaroff and Martin's Neonatal-Perinatal Medicine (11th ed., pp.
789-815). Elsevier.
Peters, S. M., and Ryan, R. M. (2023).
Common neonatal rashes and umbilical cord care. Pediatrics in Review, 44(2),
68-80. https://doi.org/10.1542/pir.2022-005655
Sawardekar, K. P. (2022). Necrotizing
fasciitis of the abdominal wall in a newborn secondary to omphalitis. Journal
of Neonatal Surgery, 11(1), 12. https://doi.org/10.47338/jns.v11.012
Sazawal, S., Dhingra, U., Ali, S. M.,
Dutta, A., Deb, S., Ame, S. M., and Black, R. E. (2020). Efficacy of chlorhexidine
application to umbilical cord on neonatal mortality in Pemba, Tanzania: A community-based
randomised controlled trial. The Lancet Global Health, 8(2), e236-e244. https://doi.org/10.1016/S2214-109X(19)30544-3
Sinha, A., Sazawal, S., Pradhan, A.,
Ramji, S., and Opiyo, N. (2015). Chlorhexidine skin or cord care for prevention
of mortality and infections in neonates. Cochrane Database of Systematic Reviews,
2015(3), CD007835. https://doi.org/10.1002/14651858.CD007835.pub2
Stewart, D., Benitz, W., and Committee
on Fetus and Newborn. (2016). Umbilical cord care in the newborn infant. Pediatrics,
138(3), e20162149. https://doi.org/10.1542/peds.2016-2149
Thwaites, C. L., Beeching, N. J.,
and Newton, C. R. (2022). Maternal and neonatal tetanus. The Lancet, 399(10322),
194-206. https://doi.org/10.1016/S0140-6736(21)01683-6
Turyasiima, M., Nduwimana, M., Kiconco,
G., and Tumwine, J. K. (2020). Bacteriology and antibiotic susceptibility patterns
among neonates diagnosed of omphalitis at a tertiary special care baby unit in western
uganda. International Journal of Pediatrics, 2020, 4131098. https://doi.org/10.1155/2020/4131098
Van Heerden, J., Ben-Israel, O., and
Koplewitz, B. Z. (2023). Sonography of the neonatal abdomen and pelvis. Pediatric
Radiology, 53(5), 875-891. https://doi.org/10.1007/s00247-022-05560-y
World Health Organization (WHO). (2022).
WHO recommendation on topical application of chlorhexidine to the umbilical cord
for prevention of neonatal sepsis. https://www.who.int/publications/i/item/9789240021455